Increase in Patient Population to Propel Market
Increase in incidence and prevalence of cancer across the globe is projected to drive the global radiation therapy market during the forecast period, as radiation therapy is used in nearly 50% of all cancer treatments. Rise in the number of cancer patients across the world is anticipated to propel demand for therapeutics. According to the American Institute of Cancer Research, around 18 million cancer cases were diagnosed globally in 2018 and head & neck cancer accounted for about 4% of all cancers in the U.S. in 2017. Moreover, an estimated 65,000 individuals will develop head & neck cancer in the near future.
Request a PDF Sample of Radiation Therapy Market Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36080
Technological Advancements
Increase in demand for highly efficient radiation therapy systems for cancer treatment and new product approvals are projected to augment the global radiation therapy market during the forecast period. The global market has witnessed an increase in new product approvals in the past few years. This is anticipated to propel the global market from 2018 to 2026. For instance, in February 2019, ViewRay, Inc. received 510(k) clearance from the U.S. FDA to market new soft tissue visualization capabilities for the MRIdian system. The system is expected to help clinicians in the assessment and prediction of radiation therapy.
Asia Pacific Market to Grow at a Rapid Pace
In terms of revenue, the radiation therapy market in Asia Pacific is projected to expand at a high CAGR during the forecast period. Rapidly increasing patient population in the region and rise in product launches are anticipated to boost demand for radiation therapy systems, which in turn is expected to drive the market from 2018 to 2026. Increase in government expenditure in the health care segment is likely to fuel the growth of the radiation therapy market in Asia Pacific during the forecast period. According to the Union Budget of India for 2017–2018, the total health care expenditure was increased from 1.97% to 2.27% of the total budget.
Varian Medical Systems and Elekta AB Company to Lead Market
The report also provides profiles of leading players operating in the global radiation therapy market. These include Varian Medical Systems, Elekta AB, IBA Radiopharma Solutions, Accuray Incorporated, Isoray, Inc., Mevion Medical Systems, Hitachi, Ltd., ViewRay, Inc., and Panacea Medical Technologies Pvt. Ltd. Increase in mergers & acquisitions, strategic collaborations, and new product launches are expected to drive the global market during the forecast period. For instance, in November 2017, Varian Medical Systems opened a new facility in Jundiai, Brazil, to increase access to advanced radiotherapy treatment in the country and across Latin America.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving method-ologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of re-search is the key to help enterprises reach right decision.
